4DO3
Structure of FAAH with a non-steroidal anti-inflammatory drug
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE BM14 |
| Synchrotron site | ESRF |
| Beamline | BM14 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2011-04-23 |
| Detector | MARMOSAIC 225 mm CCD |
| Wavelength(s) | 1.0080 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 103.470, 104.370, 147.620 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 44.500 - 2.250 |
| R-factor | 0.16616 |
| Rwork | 0.164 |
| R-free | 0.19872 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3lj7 |
| RMSD bond length | 0.026 |
| RMSD bond angle | 2.034 |
| Data reduction software | MOSFLM (PACKAGE) |
| Data scaling software | SCALA |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 44.500 | 2.370 |
| High resolution limit [Å] | 2.250 | 2.250 |
| Rmerge | 0.111 | 0.578 |
| Number of reflections | 76403 | |
| <I/σ(I)> | 15.9 | 4.1 |
| Completeness [%] | 99.9 | 98.9 |
| Redundancy | 11.6 | 10.8 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 290 | 30% PEG400, 100 MM TRIS-HCL, PH 7.5, 100 MM MGCL2, 100 MM NACL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 287K, temperature 290K |






